{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:50:06Z","timestamp":1792601406750,"version":"4.5.0"},"reference-count":44,"publisher":"Instituto Nacional de Salud (Colombia)","issue":"Supl. 1","content-domain":{"domain":["revistabiomedica.org"],"crossmark-restriction":false},"short-container-title":["biomedica"],"abstract":"<jats:p>Introducci\u00f3n. Los perros de trabajo pueden infectarse con diversas serovariedades de Leptospira que se mantienen en sus t\u00fabulos renales e intersticios por mucho tiempo, por lo que se convierten en portadores y fuentes de infecci\u00f3n para otros hu\u00e9spedes.Objetivo. Establecer la prevalencia de Leptospira spp. en perros de trabajo vacunados y en poblaci\u00f3n humana con riesgo ocupacional de seis unidades policiales en Colombia.Materiales y m\u00e9todos. Mediante tres instrumentos estructurados, se evaluaron 92 perros de trabajo con inmunizaci\u00f3n previa contra Leptospira spp. (65 machos y 27 hembras) y 69 personas de seis unidades policiales de los municipios de Manizales, Pereira, Armenia, Ibagu\u00e9, Tulu\u00e1 y Cali. Se obtuvieron muestras sangu\u00edneas de las personas y de los perros, las cuales se evaluaron mediante la prueba de microaglutinaci\u00f3n (Microscopic Agglutination Test, MAT) en 24 serogrupos. Se hizo un examen cl\u00ednico de los perros y se obtuvieron muestras de orina para urocultivo.Resultados. La seroprevalencia de leptospirosis en las personas fue de 2,9 % (n=2) y en los perros de 57,61 % (n=53). Los serogrupos m\u00e1s prevalentes en los perros fueron Leptospira canicola y L. panama. El urocultivo fue positivo en 58,7 % (54\/92) de las muestras y se encontr\u00f3 asociaci\u00f3n estad\u00edsticamente significativa entre la edad de los perros (\u226510 a\u00f1os; p=0,043) y la ubicaci\u00f3n de la unidad policial (p=0,016).Conclusi\u00f3n. Las caracter\u00edsticas epidemiol\u00f3gicas de la leptospirosis en los perros sugieren una presentaci\u00f3n end\u00e9mica de la infecci\u00f3n. Se requieren algoritmos diagn\u00f3sticos sensibles y espec\u00edficos para investigar la leptospirosis canina y diferenciar los anticuerpos vacunales de la infecci\u00f3n natural.<\/jats:p>","DOI":"10.7705\/biomedica.5009","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T21:32:34Z","timestamp":1590615154000},"page":"62-75","update-policy":"https:\/\/doi.org\/10.7705\/crossmark","source":"Crossref","is-referenced-by-count":13,"title":["Prevalencia de leptospirosis en perros de trabajo vacunados y en poblaci\u00f3n humana con riesgo ocupacional"],"prefix":"10.7705","volume":"40","author":[{"given":"C\u00e9sar A.","family":"Murcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miryam","family":"Astudillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7143-7339","authenticated-orcid":false,"given":"Marlyn H.","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4444","published-online":{"date-parts":[[2020,5,1]]},"reference":[{"key":"97535","doi-asserted-by":"crossref","unstructured":"Delaude A, Rodr\u00edguez-Campos S, Dreyfus A, Counotte MJ, Francey T, Schweighauser A, et al. Canine leptospirosis in Switzerland\u2014A prospective cross-sectional study examining seroprevalence, risk factors and urinary shedding of pathogenic leptospires. Prev Vet Med. 2017;141:48-60. https:\/\/doi.org\/10.1016\/j.prevetmed.2017.04.008","DOI":"10.1016\/j.prevetmed.2017.04.008"},{"key":"97536","doi-asserted-by":"crossref","unstructured":"Martin L, Wiggans K, Wennogle S, Curtis K, Chandrashekar R, Lappin M. Vaccine associated Leptospira antibodies in client-owned dogs. J Vet Intern Med. 2014;28:789-92. https:\/\/doi.org\/10.1111\/jvim.12337","DOI":"10.1111\/jvim.12337"},{"key":"97537","doi-asserted-by":"crossref","unstructured":"Garba B, Bahaman AR, Bejo SK, Zakaria Z, Mutalib AR, Bande F. Major epidemiological factors associated with leptospirosis in Malaysia. Acta Trop. 2018;178:242-7. https:\/\/doi.org\/10.1016\/j.actatropica.2017.12.010","DOI":"10.1016\/j.actatropica.2017.12.010"},{"key":"97538","doi-asserted-by":"crossref","unstructured":"Andr\u00e9-Fontaine G. Canine leptospirosis\u2014Do we have a problem? Vet Microbiol. 2006;117:19-24. https:\/\/doi.org\/10.1016\/j.vetmic.2006.04.005","DOI":"10.1016\/j.vetmic.2006.04.005"},{"key":"97539","doi-asserted-by":"crossref","unstructured":"Andre-Fontaine G, Aviat F, Marie J-L, Chatrenet B. Undiagnosed leptospirosis cases in na\u00efve and vaccinated dogs: Properties of a serological test based on a synthetic peptide derived from Hap1\/LipL32 (residues 154-178). Comp Immunol Microbiol Infect Dis. 2015;39:1-8. https:\/\/doi.org\/10.1016\/j.cimid.2014.12.002","DOI":"10.1016\/j.cimid.2014.12.002"},{"key":"97540","doi-asserted-by":"crossref","unstructured":"Andre-Fontaine G. Diagnosis algorithm for leptospirosis in dogs: Disease and vaccination effects on the serological results. Vet Rec. 2013;172:502. https:\/\/doi.org\/10.1136\/vr.101333","DOI":"10.1136\/vr.101333"},{"key":"97541","doi-asserted-by":"crossref","unstructured":"Romero MH, Astudillo M, Aguill\u00f3n DM, Lucio ID. Evidencia serol\u00f3gica de leptospirosis canina en la comunidad ind\u00edgena Kaments\u00e1, Putumayo, Colombia. Rev Investig Vet Per\u00fa. 2018;29:625-34. https:\/\/doi.org\/10.15381\/rivep.v29i2.14495","DOI":"10.15381\/rivep.v29i2.14495"},{"key":"97542","doi-asserted-by":"crossref","unstructured":"Romero-Vivas CM, Falconar AK. Leptospira spp. y leptospirosis humana. Revista Salud Uninorte. 2016;32:123-43. https:\/\/doi.org\/10.14482\/sun.32.1.8479","DOI":"10.14482\/sun.32.1.8479"},{"key":"97543","doi-asserted-by":"crossref","unstructured":"Roqueplo C, Mari\u00e9 J-L, Andr\u00e9-Fontaine G, Kodjo A, Davoust B. Serological survey of canine leptospirosis in three countries of tropical Africa: Sudan, Gabon and Ivory Coast. Comp Immunol Microbiol Infect Dis. 2015;38:57-61. https:\/\/doi.org\/10.1016\/j.cimid.2014.10.006","DOI":"10.1016\/j.cimid.2014.10.006"},{"key":"97544","doi-asserted-by":"crossref","unstructured":"Levett PN. Leptospirosis. Clin Microbiol Rev. 2001;14:296-326. https:\/\/doi.org\/10.1128\/cmr.14.2.296-326.2001","DOI":"10.1128\/CMR.14.2.296-326.2001"},{"key":"97545","doi-asserted-by":"crossref","unstructured":"Agudelo-Fl\u00f3rez P, Restrepo-Jaramillo BN, Arboleda-Naranjo M. Situaci\u00f3n de la leptospirosis en el Urab\u00e1 antioque\u00f1o colombiano: estudio seroepidemiol\u00f3gico y factores de riesgo en poblaci\u00f3n general urbana. Cad Sa\u00fade P\u00fablica. 2007;23:2094-102. https:\/\/doi.org\/10.1590\/s0102-311x2007000900017","DOI":"10.1590\/S0102-311X2007000900017"},{"key":"97546","doi-asserted-by":"crossref","unstructured":"Romero MH, S\u00e1nchez JA, Hayek LC. The prevalence of antibodies against Leptospira in urban human and canine populations from the Tolima department. Rev Salud P\u00fablica (Bogot\u00e1). 2010;12:268-75. https:\/\/doi.org\/10.1590\/S0124-00642010000200010","DOI":"10.1590\/S0124-00642010000200010"},{"key":"97547","doi-asserted-by":"crossref","unstructured":"Medrano-Galarza C, D\u00edaz-Rojas CA, Dalmau-Barros EA. Diagn\u00f3stico de leptospirosis canina por medio de las t\u00e9cnicas Dot-ELISA y MAT en perros con enfermedad renal en Bogot\u00e1. Rev Med Vet. 2011;21:133-45. https:\/\/doi.org\/10.19052\/mv.568","DOI":"10.19052\/mv.568"},{"key":"97548","doi-asserted-by":"crossref","unstructured":"Levett PN. Leptospirosis: A forgotten zoonosis? Clin Appl Immunol Rev. 2004;4:435-48. https:\/\/doi.org\/10.1016\/j.cair.2004.08.001","DOI":"10.1016\/j.cair.2004.08.001"},{"key":"97549","doi-asserted-by":"crossref","unstructured":"White AM, Zambrana-Torrelio C, Allen T, Rostal MK, Wright AK, Ball EC, et al. Hotspots of canine leptospirosis in the United States of America. Vet J. 2017;222:29-35. https:\/\/doi.org\/10.1016\/j.tvjl.2017.02.009","DOI":"10.1016\/j.tvjl.2017.02.009"},{"key":"97550","unstructured":"Organizaci\u00f3n Mundial de Sanidad Animal. Manual de las pruebas de diagn\u00f3stico y de las vacunas para los animales terrestres (mam\u00edferos, aves y abejas). Quinta edici\u00f3n. Par\u00eds: OIE; 2004. p. 1260."},{"key":"97551","doi-asserted-by":"crossref","unstructured":"Faine S, Adler B, Bolin C, Perolat P. Clinical leptospirosis in humans. Leptospira and leptospirosis. Armadale, Australia: MedSci; 1999. https:\/\/doi.org\/10.1016\/S0378-1135(01)00319-4","DOI":"10.1016\/S0378-1135(01)00319-4"},{"key":"97552","doi-asserted-by":"crossref","unstructured":"Adler B, de la Pe\u00f1a-Moctezuma A. Leptospira and leptospirosis. Vet Microbiol. 2010;140:287-96. https:\/\/doi.org\/10.1016\/j.vetmic.2009.03.012","DOI":"10.1016\/j.vetmic.2009.03.012"},{"key":"97553","doi-asserted-by":"crossref","unstructured":"Sedano A, Pinto C, Siuce J, Calle S. Estandarizaci\u00f3n e implementaci\u00f3n de una t\u00e9cnica de qPCR para la detecci\u00f3n de Leptospira spp. pat\u00f3genas en muestras de orina de caninos dom\u00e9sticos. Revista de Investigaciones Veterinarias del Per\u00fa. 2016;27:158. https:\/\/doi.org\/10.15381\/rivep.v27i1.11454","DOI":"10.15381\/rivep.v27i1.11454"},{"key":"97554","doi-asserted-by":"crossref","unstructured":"Arent Z, Andrews S, Adamama-Moraitou K, Gilmore C, Pardali D, Ellis W. Emergence of novel Leptospira serovars: A need for adjusting vaccination policies for dogs? Epidemiol Infect. 2013;141:1148-53. https:\/\/doi.org\/10.1017\/s0950268812002087","DOI":"10.1017\/S0950268812002087"},{"key":"97555","doi-asserted-by":"crossref","unstructured":"Sant\u2019Anna R, Vieira AS, Oliveira J, Lilenbaum W. Asymptomatic leptospiral infection is associated with canine chronic kidney disease. Comp Immunol Microbiol Infect Dis. 2019;62:64-7. https:\/\/doi.org\/10.1016\/j.cimid.2018.11.009","DOI":"10.1016\/j.cimid.2018.11.009"},{"key":"97556","doi-asserted-by":"crossref","unstructured":"Adler B. Vaccines against leptospirosis. Leptospira and leptospirosis: Berlin: Springer; 2015. p. 251-72. https:\/\/doi.org\/10.1007\/978-3-662-45059-8_10","DOI":"10.1007\/978-3-662-45059-8_10"},{"key":"97557","doi-asserted-by":"crossref","unstructured":"Romero P, S\u00e1nchez V. Seroprevalencia de la leptospirosis canina de tres municipios del departamento del Tolima-Colombia. Revista MVZ C\u00f3rdoba. 2009;14:1684-9. https:\/\/doi.org\/10.21897\/rmvz.351","DOI":"10.21897\/rmvz.351"},{"key":"97558","doi-asserted-by":"crossref","unstructured":"Klaasen HLBM, Molkenboer MJCH, Vrijenhoek MP, Kaashoek MJ. Duration of immunity in dogs vaccinated against leptospirosis with a bivalent inactivated vaccine. Vet Microbiol. 2003;95:121-32. https:\/\/doi.org\/10.1016\/S0378-1135(03)00152-4","DOI":"10.1016\/S0378-1135(03)00152-4"},{"key":"97559","doi-asserted-by":"crossref","unstructured":"Miller M, Annis K, Lappin M, Lunn K. Variability in results of the microscopic agglutination test in dogs with clinical leptospirosis and dogs vaccinated against leptospirosis. J Vet Intern Med. 2011;25:426-32. https:\/\/doi.org\/10.1111\/j.1939-1676.2011.0704.x","DOI":"10.1111\/j.1939-1676.2011.0704.x"},{"key":"97560","doi-asserted-by":"crossref","unstructured":"Andr\u00e9-Fontaine G, Branger C, Gray AW, Klaasen HL. Comparison of the efficacy of three commercial bacterins in preventing canine leptospirosis. Vet Rec. 2003;153:165-9. https:\/\/doi.org\/10.1136\/vr.153.6.165","DOI":"10.1136\/vr.153.6.165"},{"key":"97561","doi-asserted-by":"crossref","unstructured":"Minke JM, Bey R, Tronel JP, Latour S, Colombet G, Yvorel J, et al. Onset and duration of protective immunity against clinical disease and renal carriage in dogs provided by a bivalent inactivated leptospirosis vaccine. Vet Microbiol. 2009;137:137-45. https:\/\/doi.org\/10.1016\/j.vetmic.2008.12.021","DOI":"10.1016\/j.vetmic.2008.12.021"},{"key":"97562","doi-asserted-by":"crossref","unstructured":"Hartskeerl RA, Smythe LD. The role of leptospirosis reference laboratories. Leptospira and Leptospirosis: Berl\u00edn: Springer; 2015. p. 273-88. https:\/\/doi.org\/10.1007\/978-3-662-45059-8_11","DOI":"10.1007\/978-3-662-45059-8_11"},{"key":"97563","doi-asserted-by":"crossref","unstructured":"Schreiber P, Martin V, Najbar W, Sanquer A, Gueguen S, Lebreux B. Prevention of renal infection and urinary shedding in dogs by a Leptospira vaccination. Vet Microbiol. 2005;108:113-8. https:\/\/doi.org\/10.1016\/j.vetmic.2005.03.007","DOI":"10.1016\/j.vetmic.2005.03.007"},{"key":"97564","doi-asserted-by":"crossref","unstructured":"Grosenbaugh DA, Pardo MC. Fifteen-month duration of immunity for the serovar grippotyphosa fraction of a tetravalent canine leptospirosis vaccine. Vet Rec. 2018;182:665. https:\/\/doi.org\/10.1136\/vr.104694","DOI":"10.1136\/vr.104694"},{"key":"97565","doi-asserted-by":"crossref","unstructured":"Sykes J, Hartmann K, Lunn K, Moore G, Stoddard R, Goldstein R. 2010 ACVIM small animal consensus statement on leptospirosis: Diagnosis, epidemiology, treatment, and prevention. J Vet Intern Med. 2011;25:1-13. https:\/\/doi.org\/10.1111\/j.1939-1676.2010.0654.x","DOI":"10.1111\/j.1939-1676.2010.0654.x"},{"key":"97566","doi-asserted-by":"crossref","unstructured":"Acha PN, Szyfres B. Zoonosis y enfermedades transmisibles comunes al hombre y a los animales. Bacteriosis y micosis. Rev Inst Med Trop S Paulo. 2001;43:338. https:\/\/doi.org\/10.1590\/S0036-46652001000600015","DOI":"10.1590\/S0036-46652001000600015"},{"key":"97567","doi-asserted-by":"crossref","unstructured":"Andr\u00e9-Fontaine G, Triger L. MAT cross-reactions or vaccine cross-protection: Retrospective study of 863 leptospirosis canine cases. Heliyon. 2018;4:e00869. https:\/\/doi.org\/10.1016\/j.heliyon.2018.e00869","DOI":"10.1016\/j.heliyon.2018.e00869"},{"key":"97568","doi-asserted-by":"crossref","unstructured":"Miotto BA, da Hora AS, Taniwaki SA, Brandao PE, Heinemann MB, Hagiwara MK. Development and validation of a modified TaqMan based real-time PCR assay targeting the lipl32 gene for detection of pathogenic Leptospira in canine urine samples. Braz J Microbiol. 2018;49:584-90. https:\/\/doi.org\/10.1016\/j.bjm.2017.09.004","DOI":"10.1016\/j.bjm.2017.09.004"},{"key":"97569","doi-asserted-by":"crossref","unstructured":"Yang C-W. Leptospirosis renal disease: Emerging culprit of chronic kidney disease unknown etiology. Nephron. 2018;138:129-36. https:\/\/doi.org\/10.1159\/000480691","DOI":"10.1159\/000480691"},{"key":"97570","doi-asserted-by":"crossref","unstructured":"Sant\u2019Anna R, Vieira A, Grapiglia J, Lilenbaum W. High number of asymptomatic dogs as leptospiral carriers in an endemic area indicates a serious public health concern. Epidemiol Infect. 2017;145:1852-4. https:\/\/doi.org\/10.1017\/s0950268817000632","DOI":"10.1017\/S0950268817000632"},{"key":"97571","doi-asserted-by":"crossref","unstructured":"Joya LC, Guti\u00e9rrez DL, Hurtado WM, Gama JM. Leptospira: revisi\u00f3n del agente causal de una enfermedad zoon\u00f3tica. Biociencias. 2015;10:65-80. https:\/\/doi.org\/10.18041\/2390-0512\/bioc..2.2643","DOI":"10.18041\/2390-0512\/bioc..2.2643"},{"key":"97572","doi-asserted-by":"crossref","unstructured":"Calder\u00f3n JC, Astudillo M, Romero MH. Caracterizaci\u00f3n epidemiol\u00f3gica de la infecci\u00f3n con Leptospira spp. en caballos de trabajo y poblaci\u00f3n ocupacionalmente expuesta de seis unidades policiales colombianas. Biom\u00e9dica. 2019;39:19-34. https:\/\/doi.org\/10.7705\/biomedica.v39i1.4475","DOI":"10.7705\/biomedica.v39i1.4475"},{"key":"97573","doi-asserted-by":"crossref","unstructured":"Lelu M, Mu\u00f1oz-Zanzi C, Higgins B, Galloway R. Seroepidemiology of leptospirosis in dogs from rural and slum communities of Los R\u00edos Region, Chile. BMC Vet Res. 2015;11:31. https:\/\/doi.org\/10.1186\/s12917-015-0341-9","DOI":"10.1186\/s12917-015-0341-9"},{"key":"97574","doi-asserted-by":"crossref","unstructured":"Jorge S, Schuch RA, de Oliveira NR, da Cunha CEP, Gomes CK, Oliveira TL, et al. Human and animal leptospirosis in Southern Brazil: A five-year retrospective study. Travel Med Infect Dis. 2017;18:46-52. https:\/\/doi.org\/10.1016\/j.tmaid.2017.07.010","DOI":"10.1016\/j.tmaid.2017.07.010"},{"key":"97575","doi-asserted-by":"crossref","unstructured":"Harland A, Cave N, Jones B, Benschop J, Donald J, Midwinter A, et al. A serological survey of leptospiral antibodies in dogs in New Zealand. N Z Vet J. 2013;61:98-106. https:\/\/doi.org\/10.1080\/00480169.2012.719212","DOI":"10.1080\/00480169.2012.719212"},{"key":"97576","doi-asserted-by":"crossref","unstructured":"Hamond C, Martins G, Bremont S, Medeiros MA, Bourhy P, Lilenbaum W. Molecular characterization and serology of Leptospira kirschneri (Serogroup grippotyphosa) isolated from urine of a mare post-abortion in Brazil. Zoonoses Public Health. 2016;63:191-5. https:\/\/doi.org\/10.1111\/zph.12224","DOI":"10.1111\/zph.12224"},{"key":"97577","doi-asserted-by":"crossref","unstructured":"Romero MH, Astudillo M, S\u00e1nchez JA, Gonz\u00e1lez LM, Varela N. Anticuerpos contra Leptospira sp. en primates neotropicales y trabajadores de un zool\u00f3gico colombiano. Rev Salud P\u00fablica (Bogot\u00e1). 2011;13:814-23. https:\/\/doi.org\/10.1590\/S0124-00642011000500010","DOI":"10.1590\/S0124-00642011000500010"},{"key":"97578","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez AL, Ferro BE, Varona MX, Santaf\u00e9 M. Evidencia de exposici\u00f3n a Leptospira en perros callejeros de Cali. Biom\u00e9dica. 2004;24:291-5. https:\/\/doi.org\/10.7705\/biomedica.v24i3.1275","DOI":"10.7705\/biomedica.v24i3.1275"}],"container-title":["Biom\u00e9dica"],"original-title":[],"link":[{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/5009\/4454","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/5009\/4454","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T19:51:35Z","timestamp":1590781895000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/view\/5009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":44,"journal-issue":{"issue":"Supl. 1","published-online":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.7705\/biomedica.5009","relation":{},"ISSN":["2590-7379","0120-4157"],"issn-type":[{"value":"2590-7379","type":"electronic"},{"value":"0120-4157","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,1]]},"assertion":[{"value":"2020-05-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"Yes","order":0,"name":"peer_reviewed","label":"Peer Reviewed","group":{"name":"peer_review","label":"Peer Review"}},{"value":"Instituto Nacional de Salud","name":"publisher","label":"This article is maintained by"},{"value":"Biomedica","name":"journaltitle","label":"Journal Title"},{"value":"Original articles","name":"content_type","label":"Content Type"}]}}